Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs17-pd4-07
Abstract: Background: FGFR1 amplification (amp) occurs in ˜15% of breast cancers (BC) and associates with poor prognosis and resistance to endocrine therapy. CCND1 regulates cell cycle progression and is amplified in 15-20% of BC. Co-amp of…
read more here.
Keywords:
breast;
fgfr1 amplification;
fgfr1;
fgfr1 ccnd1 ... See more keywords